These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 900222)

  • 1. Treatment of total hyphemas with urokinase.
    Leet DM
    Am J Ophthalmol; 1977 Jul; 84(1):79-84. PubMed ID: 900222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tissue plasminogen activator in experimental hyphema.
    Lambrou FH; Snyder RW; Williams GA
    Arch Ophthalmol; 1987 Jul; 105(7):995-7. PubMed ID: 3111453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracameral urokinase for dissolution of fibrin or blood clots after glaucoma surgery.
    WuDunn D
    Am J Ophthalmol; 1997 Nov; 124(5):693-5. PubMed ID: 9372728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in outflow facility in experimental hyphema.
    Sternberg P; Tripathi RC; Tripathi BJ; Chilcote RR
    Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1388-90. PubMed ID: 7429774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical epinephrine on experimental sickle cell hyphema.
    Vernot JA; Barron BA; Goldberg MF
    Arch Ophthalmol; 1985 Feb; 103(2):280-3. PubMed ID: 3977699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of melanin on traumatic hyphema in rabbits.
    Lai WW; Bhavnani VD; Tessler HH; Edward DP
    Arch Ophthalmol; 1999 Jun; 117(6):789-93. PubMed ID: 10369591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular penetration of topical tissue plasminogen activator.
    Lim JI; Fiscella R; Tessler H; Gagliano DA; Chaques-Alepuz V; Mohler MA
    Arch Ophthalmol; 1991 May; 109(5):714-7. PubMed ID: 1902662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular tissue plasminogen activator in a rabbit model of traumatic hyphema.
    Howard GR; Vukich J; Fiscella RG; Farber MD; Goldberg MF
    Arch Ophthalmol; 1991 Feb; 109(2):272-4. PubMed ID: 1899562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thrombolytic effect of lumbrokinase is not as potent as urokinase in a rabbit cerebral embolism model.
    Kim JS; Kang JK; Chang HC; Lee M; Kim GS; Lee DK; Kim ST; Kim M; Park S
    J Korean Med Sci; 1993 Apr; 8(2):117-20. PubMed ID: 8397927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator (urokinase) causes vascularization of the cornea.
    Berman M; Winthrop S; Ausprunk D; Rose J; Langer R; Gage J
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):191-9. PubMed ID: 6173346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-type plasminogen activator to prevent haze after photorefractive keratectomy, and pregnancy as a risk factor for haze in rabbits.
    Csutak A; Silver DM; Tözsér J; Hassan Z; Berta A
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1329-33. PubMed ID: 15111585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of urokinase on central corneal thickness and vitreous haemorrhage.
    Bramsen T
    Acta Ophthalmol (Copenh); 1978 Dec; 56(6):1006-12. PubMed ID: 364920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase in the management of vitreous hemorrhage.
    Chapman-Smith JS; Crock GW
    Br J Ophthalmol; 1977 Aug; 61(8):500-5. PubMed ID: 911729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase in experimental vitreous hemorrhage.
    Koziol J; Peyman GA; Sanders DR; Vichek J; Goldberg MF
    Ophthalmic Surg; 1975; 6(3):79-82. PubMed ID: 810755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained anti-staphylococcal effect of lysostaphin in the rabbit aqueous humor.
    Balzli CL; McCormick CC; Caballero AR; O'Callaghan RJ
    Curr Eye Res; 2010 Jun; 35(6):480-6. PubMed ID: 20465441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis of intracranial hematomas with urokinase in a rabbit model.
    Narayan RK; Narayan TM; Katz DA; Kornblith PL; Murano G
    J Neurosurg; 1985 Apr; 62(4):580-6. PubMed ID: 3973729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inhibition of urokinase-type plasminogen activator (u-PA) by amiloride in the cornea and tear fluid of eyes irradiated with UVB.
    Cejková J; Cejka C; Zvárová J
    Acta Histochem; 2005; 107(1):77-86. PubMed ID: 15866288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of experimental intravitreal fibrin with tissue plasminogen activator.
    Lambrou FH; Snyder RW; Williams GA; Lewandowski M
    Am J Ophthalmol; 1987 Dec; 104(6):619-23. PubMed ID: 3120591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traumatic hyphema: surgical vs medical management.
    Read J
    Ann Ophthalmol; 1975 May; 7(5):659-62, 664-6, 668-70. PubMed ID: 1137285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebleeding in experimental traumatic hyphema treated with intraocular tissue plasminogen activator.
    Williams DF; Han DP; Abrams GW
    Arch Ophthalmol; 1990 Feb; 108(2):264-6. PubMed ID: 2105713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.